Education platform Knowbox has received a new round of funding to develop cost-saving AI technology, but with regulations tightening, time is running out for these platforms to generate positive cash flows.

Biocytogen delivers gene-modified mice to speed up development in the pharmaceutical industry. Riding the momentum of biotech development in China, the firm expects to IPO within three years.

As sovereign wealth funds seek to do more co- and direct investment, real estate is experiencing the most abrupt move away from the traditional limited partner model.

China's venture capital investments got off to a weak start this year, but those in Southeast Asia and India seem to be bucking that trend, getting more attention than ever.

The global payments processor has invested in Gojek as well as earlier backing Grab.

China's dogs and cats get plenty of love from their owners, but it appears there's also plenty of interest from investors with Fullpet planning to use its Series B funding to expand its pet food business.

One private equity investor sees value in online education in an off-line environment. He also outlines the risk of surprise policy shifts by Chinese regulators.

Budweiser APAC’s IPO flop is a timely reminder for issuers and advisors to leave money on the table for prospective investors instead of squeezing every penny out of their pockets.

In Singapore, virtual banks are on the way. Will they change the landscape faster than their Hong Kong rivals?

Following a year of mega IPO flops, Chinese VC investment plummeted in the second quarter as private investors baulked at spiralling valuations. Staying private for longer will no longer be so easy for entrepreneurs.